CS
Article

i&i Biotech Fund invests €1M in Celeris Therapeutics

24 February 2022
i&i Biotech Fund invests €1M in Celeris Therapeutics

i&i Biotech Fund (i&i Bio), which is part of an innovation eco-system formed around IOCB Prague, invested €1 million in Celeris Therapeutics (CelerisTx), an early-stage drug discovery company using artificial intelligence to predict biomolecular interactions and generate new chemical entities. 

CelerisTx exploits its proprietary platform to develop new drugs in oncology and neurology. The new funds will accelerate its R&D activities.

Read more at www.inibio.eu/inibiotech-fund-invests-eur1million-in-celeris-therapeutics.

Share this article
Tags
i&i
investment
Read next...
The Advisory Committee of i&i Biotech Fund strengthened by Daniel Münich
The Advisory Committee of i&i Biotech Fund strengthened by Daniel Münich
4 January 2023
i&i Biotech Fund announces the launch of cooperation with Associate Professor Daniel Münich, who has joined the Fund's Advisory Committee. The renowned Czech economist will join…
Continue reading arrow
Experienced businessmen join forces with excellent science, invest € 2 million in the fund of IOCB Prague family
Experienced businessmen join forces with excellent science, invest € 2 million in the fund of IOCB…
30 November 2022
Leading Czech businessmen have joined to support the most promising scientific projects. Eight prominent entrepreneurs have contributed nearly €2 million to the i&i Biotech Fund …
Continue reading arrow
Student project leads to founding of startup DIANA Biotechnologies
Student project leads to founding of startup DIANA Biotechnologies
17 July 2018
A new startup, DIANA Biotechnologies, has been founded at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) to develop a unique…
Continue reading arrow
See all news arrow